| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | $41.65 | Strong Buy | $87.00 | +108.88% | a day ago | |
Analyst RankingTop 2% #93 out of 5519 analysts Average Return+44.04% Win Rate61%83 out of 135 Risk vs RewardPoor Good Analyst ColorTruist Securities's Joon Lee raised their price target on Viking Therapeutics (NASDAQ: VKTX) by 4.8% from $83 to $87 on 2026/09/23. The analyst maintained their Strong Buy rating on the stock. Lee contextualized their price target on Viking Therapeutics by observing that its VK2735 obesity data represents a "best-case scenario", having met expectations on depth, retention and tolerability. The analyst added that although management has not yet defined maintenance doses for the VANQUISH extensions because of open questions and dialogue with regulators on dose and frequency, they "sense a pull-through of both every-other-week and monthly regimens." | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||